SCHEMBL7682290

SCHEMBL7682290

CCCO[C](F)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.60
ALDH1A1 P00352 7/20 0.47
HPGD P15428 4/20 0.46
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
ELANE P08246 1/20 0.40
ESR1 P03372 1/20 0.40
CHRM1 P11229 1/20 0.40
TSHR P16473 1/20 0.40
SLC6A2 P23975 1/20 0.40
KDR P35968 1/20 0.40
KMT2A Q03164 3/20 0.40
HTT P42858 1/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CES2 O00748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7675831 0.83 KMT2A (0.47) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL2253649 0.78 LMNA (0.64) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL1449661 0.78 LMNA (0.64) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL2701951 0.77 LMNA (0.62) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL27957193 0.75 LMNA (0.60) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL3286254 0.75 LMNA (0.60) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL6057354 0.75 LMNA (0.66) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL130761 0.75 LMNA (1.00) LMNAALDH1A1HPGDSMN1; SMN2TDP1
SCHEMBL27624901 0.75 TSHR (0.39) LMNAALDH1A1HPGDTDP1TSHR
SCHEMBL7181498 0.75 LMNA (1.00) LMNAALDH1A1HPGDSMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed